Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.
2.

In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.

Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO.

Arch Gen Psychiatry. 1999 Feb;56(2):185-92.

PMID:
10025444
3.

Proton spectroscopy of human brain: effects of age and sex.

Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, Doraiswamy PM, McDonald WM.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct;18(6):995-1004.

PMID:
7824764
4.

Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.

Wiedermann D, Schuff N, Matson GB, Soher BJ, Du AT, Maudsley AA, Weiner MW.

Magn Reson Imaging. 2001 Oct;19(8):1073-80.

PMID:
11711231
5.

Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T.

Hetherington HP, Mason GF, Pan JW, Ponder SL, Vaughan JT, Twieg DB, Pohost GM.

Magn Reson Med. 1994 Nov;32(5):565-71.

PMID:
7808257
6.

MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain.

Lundbom N, Barnett A, Bonavita S, Patronas N, Rajapakse J, Tedeschi, Di Chiro G.

Magn Reson Med. 1999 Apr;41(4):841-5.

7.

Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.

Warrington CD, Feeney DA, Ober CP, Jessen CR, Steward SM, Armién AG, Fletcher TF.

Am J Vet Res. 2013 Oct;74(10):1291-303. doi: 10.2460/ajvr.74.10.1291.

PMID:
24066913
8.

Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities.

Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SN, Deicken R, Van Dyke C, Fein G, Weiner MW.

Magn Reson Med. 1992 Aug;26(2):313-27.

PMID:
1513253
9.

Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.

Wang Y, Jia Y, Xu G, Ling X, Liu S, Huang L.

J Affect Disord. 2012 Feb;136(3):620-6. doi: 10.1016/j.jad.2011.10.020. Epub 2011 Nov 29.

PMID:
22129769
10.

Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.

Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK.

Drug Alcohol Depend. 2007 Apr 17;88(1):28-35. Epub 2006 Nov 7.

PMID:
17084995
11.

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A.

Arch Gen Psychiatry. 1998 Apr;55(4):346-52.

PMID:
9554430
12.

Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.

Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.

J Hepatol. 2013 Oct;59(4):651-7. doi: 10.1016/j.jhep.2013.05.008. Epub 2013 May 13.

PMID:
23680314
13.

Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T.

Kirov II, Fleysher L, Fleysher R, Patil V, Liu S, Gonen O.

Magn Reson Med. 2008 Oct;60(4):790-5. doi: 10.1002/mrm.21715.

14.

Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.

Schuff N, Ezekiel F, Gamst AC, Amend DL, Capizzano AA, Maudsley AA, Weiner MW.

Magn Reson Med. 2001 May;45(5):899-907.

15.

Quantitative proton MR spectroscopic imaging of the human brain.

Soher BJ, van Zijl PC, Duyn JH, Barker PB.

Magn Reson Med. 1996 Mar;35(3):356-63.

PMID:
8699947
16.

Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter.

McLean MA, Woermann FG, Barker GJ, Duncan JS.

Magn Reson Med. 2000 Sep;44(3):401-11.

17.

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.

Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW.

Ann Neurol. 1994 Jul;36(1):40-7.

PMID:
8024260
18.

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.

Neurology. 2005 Jan 25;64(2):304-10.

PMID:
15668429
19.

The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium.

Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O.

Magn Reson Imaging. 1993;11(6):799-806.

PMID:
8371635
20.

Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain.

Doyle TJ, Bedell BJ, Narayana PA.

Magn Reson Med. 1995 Jun;33(6):755-9.

PMID:
7651110

Supplemental Content

Support Center